Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) Stock Information | RedChip

Virpax Pharmaceuticals Inc. (NASDAQ: VRPX)


$0.7198
+0.0008 ( +0.11% ) 62.8K

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Market Data


Open


$0.7198

Previous close


$0.7190

Volume


62.8K

Market cap


$3.51M

Day range


$0.6680 - $0.7230

52 week range


$0.3625 - $8.0000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 May 02, 2024
8-k 8K-related 15 Apr 30, 2024
8-k 8K-related 13 Apr 03, 2024
10-k Annual reports 76 Mar 26, 2024
8-k 8K-related 15 Mar 26, 2024
8-k 8K-related 13 Mar 18, 2024
8-k 8K-related 17 Mar 01, 2024
4 Insider transactions 2 Jan 31, 2024
4 Insider transactions 2 Jan 31, 2024
4 Insider transactions 2 Jan 31, 2024

Latest News